TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Momentum & Trend

Richard Moglen: 1 Week Top Performers

38 Hits · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Methodology & criteria

Moglen's weekly watchlist (TraderLion): the strongest liquid stocks of the past trading week — at least +15% over the last 4 trading days, average dollar volume ≥ $10M, and RS rating ≥ 70. Thresholds calibrated by TickerGuard (Moglen's original values aren't public); the purpose is the same: whatever leads the pack this week belongs on next week's watchlist.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(16)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Liquidity
How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Relative Strength (RS Rating)
How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.

View all terms in the Scanner Glossary

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Richard Moglen: 1 Week Top Performers
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
MXL MaxLinear Inc 07/22 +69 % ⚠ Wildest 10% 113 % Stage 2 B 64 4 of 9 6.7 $ Semiconductors Sells AI
Read
— Technology 75.00 $ +411.1 % +518.4 % +364.1 % −11.1 % +26.1 % 99 8 10.9 % 11.9 % 3.95 — 25.1 11.8 13.2 2,037.3 0.39 12.3 -12.2 % 57.5 % -18.2 % -27.9 % -4.9 % 0.33 58.9 % +29.7 % 4 0.0 % 0.0 % 2.4 87.4 % 6.9 % 4.2 (11)
ERAS Erasca Inc 08/11 +154 % ⚠ Wildest 10% 108 % Stage 2 D 27 2 of 9 4.9 $ Biotechnology Uses AI
Read
— Healthcare 15.30 $ +305.1 % +433.2 % +818.6 % −38.4 % +57.6 % 99 42 8.6 % 8.3 % 0.65 — 0.0 — 12.0 — — -1.6 0.0 % — 0.0 % -69.9 % -21.4 % 0.12 85.3 % — 3 0.0 % 0.0 % 1.0 93.3 % 9.9 % 4.6 (8)
UCTT Ultra Clean Holdings Inc 07/27 +70 % ⚠ Wildest 10% 88 % Stage 2 C 50 2 of 9 3.3 $ Semiconductor Equipment & Materials Uses AI
Read
— Technology 67.50 $ +340.7 % +399.2 % +160.7 % −3.5 % +103.0 % 98 17 8.9 % 8.7 % 1.88 — 10.5 1.5 4.9 — 0.30 24.9 2.1 % 15.8 % -1.1 % -22.5 % 2.1 % 1.52 33.9 % -2.1 % 5 0.0 % 0.0 % 6.3 102.9 % 10.7 % 4.8 (4)
DFTX Definium Therapeutics, Inc. 07/30 +332 % 74 % Stage 2 D 26 1 of 9 5.1 $ Biotechnology Neutral
Read
— Healthcare 38.70 $ +170.2 % +246.6 % +304.2 % −4.7 % +67.4 % 98 50 14.0 % 8.8 % 2.24 — 0.0 — 19.3 — — 0.0 0.0 % — 0.0 % -94.7 % -20.6 % — 69.5 % — — 0.0 % 0.0 % 1.4 65.6 % 7.4 % —
BAND Bandwidth Inc 10/29 +106 % ⚠ Wildest 10% 90 % Stage 2 C 51 7 of 9 1.6 $ Software - Infrastructure Sells AI
Read
— Technology 50.50 $ +241.3 % +304.3 % +176.2 % −31.1 % +40.1 % 98 42 8.6 % 8.7 % 3.03 — 23.0 2.1 3.6 21.1 — 32.6 -2.2 % 37.2 % 0.3 % -1.4 % -0.9 % 1.04 41.2 % +0.7 % 3 0.0 % 0.0 % 3.6 80.1 % 14.7 % 3.3 (6)
SLS Sellas Life Sciences Group Inc 08/11 +148 % ⚠ Wildest 10% 104 % Stage 2 B 58 3 of 9 2.3 $ Biotechnology Uses AI
Read
— Healthcare 11.50 $ +140.6 % +444.0 % +582.3 % −4.8 % +177.8 % 98 50 12.4 % 11.1 % 2.53 — 0.0 — — — — -1.7 0.0 % — 0.0 % -43.6 % -23.3 % — 94.1 % -100.0 % 1 0.0 % 0.0 % 16.0 27.6 % 28.8 % 4.7 (3)
ACMR Acm Research Inc 08/05 +247 % ⚠ Wildest 10% 87 % Stage 2 B 66 3 of 9 4.6 $ Semiconductor Equipment & Materials Neutral
Read
— Technology 67.80 $ +151.3 % +196.5 % +100.7 % −4.1 % +73.7 % 97 24 10.7 % 10.4 % 1.95 48.7 23.9 4.5 2.9 — — 12.7 15.6 % 43.8 % 14.5 % 7.6 % 3.2 % 0.21 51.6 % +15.2 % 6 0.0 % 0.0 % 9.7 74.2 % 7.3 % 4.3 (9)
BFLY Butterfly Network Inc 08/07 +88 % ⚠ Wildest 10% 116 % Stage 2 B 58 3 of 9 2.0 $ Medical Devices – — — Healthcare 8.00 $ +101.8 % +125.6 % +388.3 % −10.3 % +33.3 % 97 42 15.1 % 10.2 % 2.09 — 0.0 17.7 10.5 — — -9.6 -50.8 % 68.2 % -66.8 % -35.2 % -10.5 % 0.10 66.9 % +19.0 % 5 0.0 % 0.0 % -2.4 55.8 % 15.9 % 5.0 (4)
MBX MBX Biosciences, Inc. 08/06 — ⚠ Wildest 10% 105 % Stage 2 D 34 3 of 9 2.9 $ Biotechnology Neutral
Read
— Healthcare 63.90 $ +47.1 % +67.7 % +542.8 % −4.1 % +38.3 % 97 42 8.5 % 7.7 % 0.04 — 0.0 — 7.0 — — 0.0 0.0 % — 0.0 % -25.7 % -22.1 % 0.00 96.7 % — 2 0.0 % 0.0 % 37.2 111.5 % 12.1 % 4.6 (5)
ATEX Anterix Inc 08/11 +51 % 61 % Stage 2 B 66 7 of 9 1.5 $ Telecom Services Neutral
Read
— Communication Services 77.40 $ +266.4 % +339.9 % +263.0 % −8.1 % +45.1 % 97 85 8.3 % 8.2 % 0.84 17.7 0.0 203.2 6.3 100.2 — -12.4 — 100.0 % 933.0 % 43.3 % -5.9 % 0.02 — +7.8 % 6 0.0 % 0.0 % 3.5 91.8 % 13.3 % 4.7 (3)
FCEL FuelCell Energy Inc — -22 % ⚠ Wildest 10% 132 % Stage 2 C 51 4 of 9 1.3 $ Electrical Equipment & Parts Neutral
Read
— Industrials 17.70 $ +198.5 % +239.8 % +131.5 % −29.0 % +15.8 % 97 42 20.4 % 18.0 % 2.36 — 17.1 8.7 1.6 — 0.36 3,082.7 — -32.4 % -113.6 % -30.7 % -7.9 % 0.22 — +41.1 % 5 0.0 % 0.0 % 1.4 38.6 % 25.2 % 2.6 (8)
VSAT ViaSat Inc 08/04 +22 % 79 % Stage 2 B 56 8 of 9 10.0 $ Communication Equipment Uses AI
Read
— Technology 73.00 $ +85.4 % +118.2 % +125.7 % −33.2 % +42.4 % 96 73 9.0 % 9.1 % 1.70 — 144.9 2.2 2.1 12.5 0.26 8.3 -1.8 % 33.2 % -0.6 % 0.1 % 0.4 % 2.29 30.6 % +2.7 % 3 0.0 % 0.0 % 4.6 98.3 % 9.3 % 4.2 (9)
TWST Twist Bioscience Corp 08/03 +131 % 73 % Stage 2 D 41 4 of 9 9.7 $ Diagnostics & Research Threatened
Read
— Healthcare 155.60 $ +168.0 % +192.9 % +476.8 % −1.8 % -31.7 % 96 42 7.7 % 7.8 % 2.22 — 0.0 22.4 20.0 — — -35.3 -34.9 % 52.0 % -31.7 % -18.2 % -13.1 % 0.21 67.3 % +20.3 % 5 0.0 % 0.0 % -0.1 123.8 % 23.0 % 4.2 (12)
ABSI Absci Corp 08/11 +106 % ⚠ Wildest 10% 103 % Stage 2 D 33 3 of 9 1.6 $ Biotechnology Sells AI — — Healthcare 9.30 $ +112.3 % +218.8 % +263.5 % −9.2 % +54.8 % 96 42 16.7 % 12.8 % 2.44 — 0.0 1,004.4 8.1 — — -0.4 — -5,395.6 % 0.0 % -63.9 % -34.1 % 0.03 — -38.2 % 4 0.0 % 0.0 % -0.3 72.9 % 26.1 % 4.6 (9)
GLUE Monte Rosa Therapeutics Inc 08/06 +19 % 83 % Stage 2 D 36 4 of 9 1.1 $ Biotechnology Uses AI
Read
— Healthcare 12.60 $ +32.1 % +35.5 % +98.1 % −16.0 % +105.0 % 96 50 8.1 % 6.8 % 1.50 — 10.9 37.0 1.9 — — 51.9 — -465.2 % 0.0 % -32.6 % -21.6 % 0.08 — +63.5 % 4 0.0 % 0.0 % 7.7 113.2 % 21.5 % 4.6 (9)
BLZE Backblaze Inc 08/06 +57 % ⚠ Wildest 10% 101 % Stage 3 B 64 5 of 9 0.8 $ Software - Infrastructure Uses AI
Read
— Technology 13.80 $ +150.2 % +211.9 % +44.7 % −8.2 % +65.5 % 96 42 14.6 % 9.7 % 1.57 — 76.3 5.0 — 34.8 — 80.8 — 62.3 % -13.1 % -27.6 % -3.5 % — — +14.3 % 5 0.0 % 0.0 % -0.3 48.9 % 7.1 % 4.8 (6)
TXG 10X Genomics Inc 08/06 -14 % 71 % Stage 2 C 46 6 of 9 10.1 $ Health Information Services Uses AI
Read
— Healthcare 77.00 $ +95.4 % +122.6 % +498.5 % −3.1 % -32.3 % 95 42 8.2 % 7.9 % 2.08 — 1,250.0 16.4 12.2 83.2 — 148.5 -11.3 % 70.1 % -12.2 % -3.0 % -5.1 % 0.10 80.2 % +5.3 % 4 0.0 % 0.0 % 6.5 113.8 % 18.2 % 3.8 (16)
PVLA Palvella Therapeutics, Inc 08/13 +73 % 81 % Stage 2 D 26 3 of 9 2.2 $ Biotechnology – — — Healthcare 154.30 $ +13.4 % +46.3 % +172.8 % −9.9 % +49.4 % 95 42 7.0 % 6.4 % — — 0.0 — 9.8 — — 0.0 — — 0.0 % -34.3 % -22.1 % 0.00 — -100.0 % 3 0.0 % 0.0 % 14.3 96.4 % 18.0 % 4.8 (9)
APPS Digital Turbine Inc 08/04 -13 % ⚠ Wildest 10% 93 % Stage 2 B 69 6 of 9 1.4 $ Software - Application Uses AI
Read
— Technology 11.00 $ +85.2 % +140.0 % +111.2 % −5.9 % +56.1 % 95 17 10.7 % 12.7 % 2.88 — 285.7 2.3 — 63.6 0.69 15.6 — 49.1 % -5.8 % -21.8 % 4.7 % — — +15.2 % 5 0.0 % 0.0 % 0.9 66.7 % 8.7 % 3.5 (2)
IRDM Iridium Communications Inc 07/23 -8 % 60 % Stage 2 D 44 6 of 9 5.0 $ Telecom Services Neutral
Read
— Communication Services 47.50 $ +156.4 % +216.6 % +163.5 % −22.3 % -11.6 % 94 21 9.0 % 8.0 % 0.88 49.5 23.9 5.7 11.1 17.4 1.84 15.6 23.2 % 71.9 % 10.5 % 21.4 % 5.1 % 4.77 18.5 % +4.9 % 6 1.3 % 59.3 % 4.1 90.1 % 2.8 % 4.6 (9)
IBRX Immunitybio Inc 08/04 +57 % ⚠ Wildest 10% 99 % Stage 2 C 49 3 of 9 8.8 $ Biotechnology Uses AI
Read
— Healthcare 8.50 $ +269.7 % +309.8 % +206.5 % −37.3 % +50.0 % 94 42 7.8 % 7.0 % 0.14 — 116.3 53.0 — — — -9.0 -157.9 % 99.3 % 0.0 % 0.0 % -30.5 % — -134.5 % +668.3 % 6 0.0 % 0.0 % -23.1 17.6 % 31.3 % 4.6 (5)
MEI Methode Electronics Inc — -18 % ⚠ Wildest 10% 94 % Stage 2 D 43 3 of 9 0.5 $ Electronic Components Uses AI
Read
— Technology 13.50 $ +104.6 % +185.0 % +71.2 % −2.3 % +66.7 % 94 2 13.1 % 9.7 % 1.54 — 10.2 0.5 0.7 — 0.78 10.8 — 19.8 % -3.5 % -9.3 % 0.5 % 0.52 — -2.8 % 4 1.4 % 36.4 % 7.2 93.1 % 9.3 % 3.7 (3)
OUST Ouster, Inc. 08/06 +244 % ⚠ Wildest 10% 105 % Stage 2 B 59 6 of 9 2.4 $ Electronic Components Sells AI
Read
— Technology 35.00 $ +108.7 % +141.8 % +14.2 % −18.8 % +69.7 % 93 42 15.3 % 13.5 % 3.25 — 0.0 11.5 — — — -0.8 -39.6 % 46.6 % -26.0 % -25.2 % -10.7 % — 72.2 % +52.5 % 5 0.0 % 0.0 % -0.7 50.0 % 9.9 % 4.3 (6)
MRVI Maravai Lifesciences Holdings Inc 08/10 -20 % 66 % Stage 2 B 61 5 of 9 2.6 $ Biotechnology – — — Healthcare 7.30 $ +65.2 % +93.6 % +158.7 % −1.6 % +1.6 % 93 19 5.9 % 5.5 % 0.61 — 370.4 12.7 5.1 — — 1.8 — 35.7 % -37.1 % -41.0 % -5.7 % 1.28 — -28.3 % 2 0.0 % 0.0 % 4.3 88.5 % 8.7 % 3.9 (13)
GH Guardant Health Inc 07/29 +89 % 57 % Stage 2 B 55 6 of 9 24.3 $ Diagnostics & Research Sells AI
Read
— Healthcare 183.10 $ +28.1 % +50.2 % +220.2 % −2.0 % +12.0 % 92 42 5.3 % 5.7 % 1.58 — 0.0 20.5 72.3 — — -5.4 -40.2 % 65.0 % -38.3 % -4,584.5 % -18.1 % -6.60 -9.5 % +32.9 % 3 0.0 % 0.0 % 0.1 106.0 % 8.6 % 4.7 (23)
ALGM Allegro Microsystems Inc 07/30 +12 % 66 % Stage 2 B 67 5 of 9 6.8 $ Semiconductors Sells AI
Read
— Technology 33.10 $ +110.5 % +146.3 % +7.7 % −2.5 % +65.6 % 92 15 9.2 % 8.1 % 1.91 — 33.9 7.2 5.8 77.8 — 62.8 10.4 % 47.4 % 1.5 % -1.6 % 3.0 % 0.30 67.5 % +22.8 % 5 0.0 % 0.0 % 7.0 76.2 % 13.0 % 4.6 (11)
BCAX Bicara Therapeutics Inc. 08/11 — 61 % Stage 2 D 29 1 of 9 1.5 $ Biotechnology – — — Healthcare 22.60 $ +48.5 % +69.9 % +105.9 % −5.8 % +52.8 % 92 42 6.8 % 5.8 % -0.82 — 0.0 — 2.9 — — 0.0 — — 0.0 % -32.3 % -26.1 % 0.00 — — 4 0.0 % 0.0 % 18.5 104.3 % 22.8 % 4.4 (7)
MNPR Monopar Therapeutics Inc 08/11 -10 % 68 % Stage 3 D 31 4 of 9 0.6 $ Biotechnology Neutral
Read
— Healthcare 102.70 $ +25.2 % +33.6 % +54.1 % −16.5 % +16.6 % 87 42 8.6 % 7.6 % 1.50 — 0.0 — 5.1 — — -2.4 — — 0.0 % -15.9 % -14.6 % 0.00 — -100.0 % 4 0.0 % 0.0 % 62.2 93.3 % 18.6 % 4.2 (5)
NRIX Nurix Therapeutics Inc 07/08 +30 % 59 % Stage 2 E 24 1 of 9 2.6 $ Biotechnology – — — Healthcare 25.50 $ -0.6 % +23.2 % +197.6 % −2.7 % +33.1 % 84 42 7.3 % 7.5 % 1.80 — 0.0 70.9 — — — -3.3 -1,479.4 % -827.3 % 0.0 % -61.4 % -40.1 % — 75.6 % +54.0 % 4 0.0 % 0.0 % 2.6 115.0 % 17.5 % 4.4 (18)
DAVE Dave Inc 08/05 +2,117 % 70 % Stage 2 B 74 6 of 9 4.5 $ Software - Application Uses AI
Read
— Technology 356.50 $ +43.6 % +62.5 % +63.0 % −5.8 % +24.6 % 83 86 8.5 % 8.1 % 3.84 — 17.9 7.0 — 13.8 — 21.6 38.3 % 71.8 % 34.6 % 111.6 % 31.0 % — 38.4 % +59.7 % 9 0.0 % 0.0 % 11.6 100.1 % 21.5 % 4.8 (8)
CDNA CareDx Inc 08/05 +73 % 67 % Stage 2 B 74 8 of 9 2.8 $ Diagnostics & Research – — — Healthcare 54.30 $ +33.3 % +48.4 % +279.6 % −2.0 % -0.3 % 82 42 6.2 % 5.3 % 2.43 — 151.5 6.2 8.7 33.3 — 152.2 1.5 % 70.6 % 24.2 % -2.4 % -0.3 % 0.08 76.3 % +13.8 % 5 0.0 % 0.0 % 3.7 101.8 % 11.5 % 4.1 (8)
PSNL Personalis Inc 08/04 +136 % ⚠ Wildest 10% 90 % Stage 2 D 31 3 of 9 1.7 $ Diagnostics & Research Neutral
Read
— Healthcare 16.20 $ +130.9 % +122.0 % +183.3 % 0 % -4.7 % 82 42 10.2 % 10.2 % 2.32 — 0.0 24.8 6.9 — — 0.0 -150.3 % 12.7 % -153.8 % -50.3 % -25.0 % 0.03 78.2 % -17.7 % 3 0.0 % 0.0 % 13.7 66.7 % 12.3 % 4.4 (7)
CBRL Cracker Barrel Old Country Store — -14 % 56 % Stage 2 B 55 6 of 9 1.0 $ Restaurants Neutral
Read
— Consumer Cyclical 43.80 $ +85.7 % +107.4 % -9.4 % −32.8 % +2.7 % 81 91 6.3 % 6.9 % 1.18 44.5 50.3 0.3 2.5 16.4 1.56 12.6 — 31.6 % 0.8 % 5.6 % -0.1 % 2.35 — +0.4 % 3 2.2 % 87.0 % 3.4 97.7 % 38.3 % 3.0 (8)
DK Delek US Holdings, Inc. 08/05 +38 % 54 % Stage 2 B 56 5 of 9 5.2 $ Oil & Gas Refining & Marketing Uses AI
Read
— Energy 81.60 $ +113.1 % +125.7 % +167.6 % −5.9 % -8.1 % 80 98 5.6 % 5.4 % 0.57 — 20.3 0.4 98.3 7.6 0.38 6.8 -6.7 % 10.5 % 1.9 % 3.6 % 5.5 % 11.38 4.2 % -9.5 % 3 1.3 % 6.8 % 2.0 107.7 % 11.2 % 3.6 (13)
NEO NeoGenomics Inc 08/04 -10 % 52 % Stage 3 C 53 6 of 9 2.6 $ Diagnostics & Research – — — Healthcare 19.90 $ -2.5 % +15.9 % +145.3 % −1.1 % -0.9 % 78 88 6.6 % 5.9 % 1.75 — 222.2 3.5 2.9 — 2.09 202.5 -9.3 % 43.9 % -6.8 % -11.6 % -1.9 % 0.49 61.6 % +10.1 % 4 0.0 % 0.0 % 4.8 108.4 % 14.5 % 4.2 (12)
PRG PROG Holdings Inc 07/22 +10 % 45 % Stage 2 B 57 6 of 9 1.4 $ Rental & Leasing Services Uses AI
Read
— Industrials 35.70 $ +48.2 % +34.2 % +2.8 % −8.0 % +49.7 % 76 55 4.8 % 4.3 % 1.77 9.1 6.6 0.5 1.8 4.5 0.93 1.3 14.7 % 36.2 % 5.6 % 17.6 % 15.0 % 0.80 46.4 % -2.2 % 4 1.5 % 13.5 % 5.3 109.0 % 9.8 % 4.3 (7)
ADPT Adaptive Biotechnologies Corp 08/04 +49 % 68 % Stage 3 C 53 5 of 9 4.6 $ Diagnostics & Research – — — Healthcare 28.60 $ +6.1 % +28.3 % +122.7 % −2.5 % -12.3 % 74 42 6.8 % 6.7 % 2.10 — 0.0 15.0 — — — -1.0 -27.1 % 46.9 % -20.7 % -24.0 % -4.1 % — 42.8 % +54.8 % 4 0.0 % 0.0 % -2.7 96.3 % 9.3 % 4.3 (8)
NWL Newell Brands Inc 08/07 -8 % 61 % Stage 3 C 50 3 of 9 2.4 $ Household & Personal Products Uses AI
Read
— Consumer Defensive 5.60 $ +42.5 % +70.6 % +4.4 % −11.3 % +18.9 % 70 52 7.2 % 6.8 % 0.89 — 7.3 0.3 — 14.5 0.97 16.5 2.7 % 35.5 % -3.1 % -11.2 % 3.3 % — 21.6 % -5.0 % 3 5.0 % 38.9 % 2.7 99.2 % 17.1 % 3.2 (9)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Moglen's weekly watchlist (TraderLion): the strongest liquid stocks of the past trading week — at least +15% over the last 4 trading days, average dollar volume ≥ $10M, and RS rating ≥ 70. Thresholds calibrated by TickerGuard (Moglen's original values aren't public); the purpose is the same: whatever leads the pack this week belongs on next week's watchlist.

All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 38 stocks pass this scanner's criteria (as of September 18, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?